80 Percent of Recalled Medical Devices Got Little FDA Scrutiny

Cheryl Clark, for HealthLeaders Media , February 15, 2011

Also, the concept of "substantially equivalent" has been modified over the years to allow that classification even for devices made from different materials and which use a different mechanism of action.

The FDA did not respond to a request for comment on the report.

Zuckerman, Brown and Nissen noted that the resource-challenged FDA uses the 501(k) process "because it is less expensive and enables the relatively small Center for Devices and Radiological Health (CDRH) to review thousands of devices each year."

For example, the average cost for the FDA to review a 510(k) submission "was estimated at $18,200, while a PMA submission cost the agency $870,000 to review," they wrote.

Of these recalls, the largest group were for cardiovascular use and 35 – involving 31 separate devices – and most were automated external defibrillators (AEDs) approved for resuscitation of patients in cardiac arrest. About one in five of the one million AEDs in circulation have been recalled, "and hundreds of people died due to AED malfunction," the researchers wrote. Of these 35, 23 were cleared through the 510(k) process.

The second largest high-risk recall category involved 27 general hospital devices, such as insulin pumps, intravenous infusion devices and patient lifts. Of these, 20 (74%) were cleared through the 510(k) process.

The third largest high-risk recall category involved devices used in anesthesia, including mechanical ventilators. All were cleared by the 510(k) process or were exempt.

1 | 2 | 3 | 4

Comments are moderated. Please be patient.

1 comments on "80 Percent of Recalled Medical Devices Got Little FDA Scrutiny"

Incredulous Reader (2/16/2011 at 5:26 PM)
How could this analysis have been published? So the news here is that most recalled devices were from the 510k process? since almost all devices use the 510K process how is this news? Also how many of these causes could have been detected by a clinical trial - you would not find manufacturing issues, for example. This is a very poorly done analysis.




FREE e-Newsletters Join the Council Subscribe to HL magazine


100 Winners Circle Suite 300
Brentwood, TN 37027


About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.